Guoji Yanke Zazhi (Oct 2017)

Effects and mechanism of anti-VEGF assisted PPV in the treatment of proliferative retinopathy

  • Si-Jun Fan,
  • Chun-Mei Cai,
  • Hou-Bin Huang,
  • Ge Liang

DOI
https://doi.org/10.3980/j.issn.1672-5123.2017.10.27
Journal volume & issue
Vol. 17, no. 10
pp. 1908 – 1911

Abstract

Read online

AIM: To investigate the effects and mechanism of anti-vascular endothelial growth factor(VEGF)assisted pars plana vitrectomy(PPV)in the treatment of proliferative diabetic retinopathy(PDR).METHODS: A total of 92 patients(92 eyes)with PDR treated by PPV were divided into the simple PPV group(41 patients with 41 affected eyes)and the combined treatment group(51 patients with 51 affected eyes)according to whether the patient underwent intravitreal injection of Ranibizumab(IVR). The combined treatment group was treated with IVR at 5-7d before PPV. The surgical time, times of electrocoagulation, silicone oil filling rate, the incidence of postoperative complications, LogMAR BCVA of affected eyes, levels of VEGF and pigment epithelium derived factor(PEDF)in aqueous humor and vitreous body were compared between the two groups. RESULTS: The surgical time was shorter, the times of electrocoagulation was less, the silicone oil filling rate and the incidence rates of iatrogenic retinal hole and vitreous body hematocele were lower in the combined treatment group than in the simple PPV group(PPPCONCLUSION: IVR combined with PPV can reduce the perioperative levels of VEGF and PEDF, reduce the times of electrocoagulation and the incidence of iatrogenic retinal hole and vitreous body hematocele, and improve the visual acuity of patients with PDR.

Keywords